Navigation Links
Was ability to run early man's Achilles heel?
Date:9/11/2007

eletons; we use what we know about skeletons and the muscles to build a computer model of the fossil species we are interested in.

This model is a virtual robot where we can activate muscles and get it to move its legs in a physically realistic fashion; the tricky bit is getting it to actually walk or run without falling over.

However, if we use big enough computers and let the model fall over enough times it is possible for the simulation to learn which muscles to fire and when in order to get the model to walk properly. Even better we can ask the computer to find ways of minimising fuel cost and maximising top speed since that is what we think animals have to do.

Dr Sellers initially looked at walking and his models suggested that even as early as 3.5 million years ago our human ancestors were able to walk as efficiently as modern humans. His research also showed that they preferred to walk a little slower than we do but only because they were much smaller and had quite short legs.

The team also used the computer model to look at particular parts of the human locomotion system, including the Achilles tendon, which they showed acts like a big spring to store energy during running; when the tendon was removed from the model the top running speed was greatly reduced.

We have only just started to look at running and so there are still plenty of questions to answer, said Dr Sellers. But whilst these very early fossils could walk well, our initial findings suggest that efficient running came about quite a bit later in the fossil record.

How we evolved from our common ancestor with chimpanzees six million years ago is a fundamental question. Walking upright seems to be the very first thing that distinguishes our ancestors from other apes, so finding out about this should help us map the evolutionary pathway to modern humans.

The next really interesting question is to look in more detail at running. It has bee
'/>"/>

Contact: Aeron Haworth
aeron.haworth@manchester.ac.uk
44-161-275-8383
University of Manchester
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. “Nano-scissors?laser shows precise surgical capability
2. Enzyme shown to help protect genomic stability
3. Low level of extinction during ice age linked to adaptability
4. Two chemicals boost immune cells ability to fight HIV without gene therapy
5. Molecular messengers perform a crucial role in the ability of injured nerve cells to heal themselves
6. Study shows humans have ability to track odors, much like bloodhounds
7. Variation in HIVs ability to disable host defenses contributes to rapid evolution
8. Bigger brain size matters for intellectual ability
9. Locusts built-in surface analysis ability directs them to fly overland
10. First Whole Genome Map of Genetic Variability in Parkinson’s Disease
11. A bugs life: Exceptional genomic stability yet rapid protein evolution in a carpenter ant mutualist

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/6/2009)...lebrate the 150th anniversary this month of the pu...n Institute of Biological Sciences (AIBS) is publi... Charles Darwin and his historic insights into evo... the University of California, Berkeley, and James... article, "Ten Myths About Charles Darwin," appear...
(Date:11/6/2009)...ETROIT, Nov. 6 Auburn Hills, MI-ba...) will be installing its locker system and patent-... at the U.S. Department of Health and Human Servic...ethesda, MD. The locker system will support the N...rotecting our nation,s medical research agency. T...
(Date:11/5/2009)...ational Association of Biology Teachers (NABT) wil...logical sciences at Naugatuck Valley Community Col...09 Evolution Education Award during the NABT annua...1-14 November 2009 in Denver, Colorado. , The Ev...ican Institute of Biological Sciences,(AIBS) and ...
Breaking Biology News(10 mins):Biologists, educators recognize excellence in evolution education 2HPV Tied to Rare Head and Neck Cancer 59233 1HPV Tied to Rare Head and Neck Cancer 59233 2Authoritative Report on Home Health Care Experiences Released By Press Ganey 59229 1Authoritative Report on Home Health Care Experiences Released By Press Ganey 59229 2Authoritative Report on Home Health Care Experiences Released By Press Ganey 59229 3DIA 8th Annual Electronic Submissions Conference Addresses Current Developments in eCTD around the World 59225 1DIA 8th Annual Electronic Submissions Conference Addresses Current Developments in eCTD around the World 59225 2DIA 8th Annual Electronic Submissions Conference Addresses Current Developments in eCTD around the World 59225 3
...he Attendees, Choice Awards, NEW YORK, Dec. 5 Th...xposition (NECE) at Caesars Palace, Las Vegas, Nov...nomics decision makers and,ergonomics product sell...resenting all of the 50 states and a dozen foreign...GE, GM, Johnson & Johnson, Kaiser,Permanente, Lock...
...he University of Bonn and the University of Pittsb...o cardiac tissue of mice that had suffered heart a...thmias, thereby avoiding one of the most dangerous...covery, reported in this week,s issue of Nature, h... therapies to restore damaged heart tissue., The r...
...onal Academies have studied the health effects of ...omic bombs dropped on Hiroshima and Nagasaki, Japa...sion (ABCC), the study group was reorganized in 19...on (RERF), which is now a cooperative Japan-U.S. r...tributions of former and current ABCC/RERF employe...
Other Biology News:Record Attendance at the 2007 National Ergonomics Conference and Exposition 2Implanting embryonic cardiac cells prevents arrhythmias 2Atomic bomb survivor, scientists mark 60 years of long-term radiation study 2
(Date:11/6/2009)...wire-FirstCall/ -- BioSpecifics Technologies Corp....eloping first-in-class collagenase-based products,...rd quarter ended September 30, 2009. ,, "We we..., the FDA,s Arthritis Advisory Committee unanimous... XIAFLEX(TM) for the treatment of Dupuytren,s dise...
(Date:11/6/2009)...ire/ -- Myriant Technologies LLC ("Myriant"), a pr...f renewable bio-chemicals, Uhde Corporation of Am...mbH, one of the world,s leading engineering contra...the engineering, procurement & construction (E...ed on renewable feedstocks. The execution of this...
(Date:11/6/2009)...ewswire-FirstCall/ -- ,, 3Q09 Corporate High... E.U. Marketing Authorization to Astellas Pharma E...al readiness activities Expanded management team ...nd Director, Commercial Operations Appointed Brad...mittee chairman , Upcoming 2009 Milestones:...
(Date:11/6/2009)...rstCall/ - Oncolytics Biotech Inc. (TSX:ONC, NASDA...unced updated results from a Phase II study of int...astatic to the lung in a poster presentation at th...eeting held in Miami Beach, Florida, from November...Phase II Study of Intravenous REOLYSIN (Wild-type ...
Breaking Biology Technology:Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 2Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 3Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 4Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 5Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 6Myriant Technologies LLC, Uhde Corporation of America and Uhde GmbH Announce Alliance for Engineering, Procurement & Construction of World Scale Renewable Succinic Acid Plants 2Myriant Technologies LLC, Uhde Corporation of America and Uhde GmbH Announce Alliance for Engineering, Procurement & Construction of World Scale Renewable Succinic Acid Plants 3NeurogesX Reports Third Quarter 2009 Results 2NeurogesX Reports Third Quarter 2009 Results 3NeurogesX Reports Third Quarter 2009 Results 4NeurogesX Reports Third Quarter 2009 Results 5NeurogesX Reports Third Quarter 2009 Results 6NeurogesX Reports Third Quarter 2009 Results 7NeurogesX Reports Third Quarter 2009 Results 8NeurogesX Reports Third Quarter 2009 Results 9NeurogesX Reports Third Quarter 2009 Results 10Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at CTOS Annual Meeting 2Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at CTOS Annual Meeting 3
...Oct. 10 AstraZeneca (NYSE:,AZN) today announced t...s,approved once-daily SEROQUEL XR(R) (quetiapine f...eatment of the depressive episodes associated with...sociated with bipolar I,disorder, and the maintena...therapy to lithium or divalproex. SEROQUEL XR is t...
... 10 Takeda Pharmaceutical Company,Limited ("Taked...d,Development Center, Inc., a wholly owned United ...t the U.S. Food and Drug Administration (FDA) will...tin New Drug Application,(NDA) by the Prescription...., "In our most recent discussion with the FDA, i...
...No. 2 in ranking; up six spots from last year, ST...arning recognition as a leader in biotechnology no...or being a great place to work., Monsanto, headqu...in,the 2008 Top Biotech and Pharma Employers list ...mpany moved up six spots from number eight the,pri...
Other Biology Technology:FDA Approves AstraZeneca's SEROQUEL XR(R) for the Treatment of Bipolar Depression and Bipolar Mania 2FDA Approves AstraZeneca's SEROQUEL XR(R) for the Treatment of Bipolar Depression and Bipolar Mania 3FDA Approves AstraZeneca's SEROQUEL XR(R) for the Treatment of Bipolar Depression and Bipolar Mania 4FDA Approves AstraZeneca's SEROQUEL XR(R) for the Treatment of Bipolar Depression and Bipolar Mania 5FDA Approves AstraZeneca's SEROQUEL XR(R) for the Treatment of Bipolar Depression and Bipolar Mania 6FDA Approves AstraZeneca's SEROQUEL XR(R) for the Treatment of Bipolar Depression and Bipolar Mania 7FDA Approves AstraZeneca's SEROQUEL XR(R) for the Treatment of Bipolar Depression and Bipolar Mania 8FDA Approves AstraZeneca's SEROQUEL XR(R) for the Treatment of Bipolar Depression and Bipolar Mania 9FDA Continues Review of Takeda's New Drug Application for Alogliptin (SYR-322), a DPP-4 Agent for Type 2 Diabetes 2Monsanto Recognized as Top Biotechnology Employer by Science Magazine 2
NanoDrop ND-1000 UV-Vis Spectrophotometer from NanoDrop Technologies
Propidium Iodide from Calbiochem
Mouse Anti-Human PUM2 Monoclonal Antibody, Unconjugated, Clone 1C8 from Abnova Corporation
...; Deletion Cosmid Cloning Kit enables you to prepa...mary cosmid library of genomic DNA for subsequent ...fficiency cosmid library construction is accomplis...ls. First, genomic DNA is randomly sheared by pass...
Biology Products: